Inactive Instrument
Aimmune Therapeutics, Inc. Stock
Stocks
AIMT
US00900T1079
Biotechnology & Medical Research
| 1 day | -0.29% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/13/20 A | Nestle Health Science SA (Private Equity)
| Buy | Company | 54,117,287 | 82.6848% | |
| 10/13/20 A | Others | Director | 109,372 | 0.1671% | ||
| 10/10/20 A | Tender | Chief Executive Officer | 879,672 | 1.3440% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +0.20% | - | - | 2.27B | |
| -3.42% | +4.90% | +61.15% | +87.70% | 55.98B | |
| -1.63% | -3.38% | +50.37% | +68.65% | 53.69B | |
| -2.14% | -9.13% | +2.74% | +421.65% | 23.29B | |
| -0.47% | -1.53% | -18.61% | -15.41% | 23.15B | |
| -5.95% | -2.58% | +30.67% | -9.47% | 20.58B | |
| -2.38% | -1.04% | +30.17% | -31.16% | 17.76B | |
| -4.55% | -1.95% | +192.65% | +349.58% | 16.09B | |
| -6.91% | -5.83% | +26.53% | +644.30% | 15.93B | |
| +0.23% | -2.49% | +24.26% | +187.16% | 14B | |
| Average | -2.75% | -0.43% | +44.44% | +189.22% | 26.72B | |
| Weighted average by Cap. | -2.82% | -0.88% | +44.87% | +148.95% |
Employees
-
Choose MarketScreener 
